+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oxymorphone"

Opioid Analgesics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Opioid Analgesics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Oxymorphone is an opioid analgesic drug used to treat moderate to severe pain. It is a semi-synthetic opioid derived from thebaine, an alkaloid found in the opium poppy. Oxymorphone is available in both immediate-release and extended-release formulations. The immediate-release formulation is used for the relief of acute pain, while the extended-release formulation is used for the management of chronic pain. Oxymorphone is typically prescribed for patients who have not responded to other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen. Oxymorphone is a controlled substance in many countries, and its use is subject to strict regulations. It is important to note that oxymorphone is highly addictive and can lead to physical and psychological dependence. Companies in the oxymorphone market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more